Navigation Links
Clinverse, Inc. Hosting Complimentary Webinar on Sensible Clinical Trial Management

Durham, NC (PRWEB) November 05, 2013

Clinverse, Inc., provider of the first end-to-end, cloud-based financial lifecycle system for automating global clinical payments, announced today it will host the first complimentary webinar in a series of best practices webinars designed to improve cash flow management and financial performance of clinical trials. The webinar, scheduled for Tuesday, November 12th at 2:00 pm ET/11:00 am PT, will feature Christine Pierre, President of the Society for Clinical Research Sites, and Serena Lau, Principal Associate at RH Bouchard & Associates, Inc. The webinar will be moderated by Clinverse President and Co-Founder Steve Ayala.

Entitled Sensible Trial Management: Putting Contract Terms to Work to Improve Trial Performance, this webinar will provide information outlining how sponsors and CROs can proactively provide timely reimbursement to clinical sites through a sensible approach to trial performance, eliminating unnecessary financial burden and “hidden” costs. Pierre and Lau will discuss how to integrate existing clinical systems with an automated payment process. The discussion will center around innovative ideas that help to improve communication, avoid data entry errors and increase transparency. The panelists will share best practices to help with the formulation of payment terms that can be designed at trial start-up to promote positive site behavior, improve operations and enhance site satisfaction.

To learn more about or to register for this event, please visit

About Clinverse, Inc.
Clinverse, Inc. offers the industry’s first end-to-end, cloud-based financial lifecycle system for automating clinical payments globally. Used by leading BioPharma companies, our clients benefit from reduced costs through automated financial processing and unprecedented transparency and workflow. Powered by our highly secure technology platform, our solution manages millions of global financial transactions in 140 different currencies. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
3. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
4. Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer
5. Denis Connaghan Joins Clinverse, Inc. as Chief Executive Officer
6. Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
7. Ohio State Hosting International Personalized Health Care Leaders
8. A New Year, a Completely New Type of Hosting – “PODS hosting”
9. Back by Popular Demand: Spirax Sarco is Hosting a Steam Boiler Operator Training Course
10. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
11. New Ordinance Holds Landlords Responsible To Kill Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Bully To Avoid High Exterminator Fee's
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):